nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—CFTR—nose—brain cancer	0.0693	0.106	CbGeAlD
Bumetanide—SLC22A8—choroid plexus—brain cancer	0.046	0.0705	CbGeAlD
Bumetanide—SLC12A5—ganglion—brain cancer	0.03	0.0461	CbGeAlD
Bumetanide—Azotaemia—Lomustine—brain cancer	0.0258	0.0741	CcSEcCtD
Bumetanide—SLC12A5—hindbrain—brain cancer	0.0228	0.035	CbGeAlD
Bumetanide—SLC12A4—hindbrain—brain cancer	0.0189	0.029	CbGeAlD
Bumetanide—SLC12A1—ganglion—brain cancer	0.0144	0.0222	CbGeAlD
Bumetanide—SLC12A5—brainstem—brain cancer	0.0131	0.02	CbGeAlD
Bumetanide—SLC12A5—telencephalon—brain cancer	0.0116	0.0178	CbGeAlD
Bumetanide—SLC12A4—brainstem—brain cancer	0.0108	0.0166	CbGeAlD
Bumetanide—Azotaemia—Carmustine—brain cancer	0.0103	0.0294	CcSEcCtD
Bumetanide—SLC12A4—telencephalon—brain cancer	0.00963	0.0148	CbGeAlD
Bumetanide—SLC12A5—pituitary gland—brain cancer	0.00944	0.0145	CbGeAlD
Bumetanide—Hearing impaired—Procarbazine—brain cancer	0.00917	0.0263	CcSEcCtD
Bumetanide—SLC12A5—medulla oblongata—brain cancer	0.00911	0.014	CbGeAlD
Bumetanide—Encephalopathy—Carmustine—brain cancer	0.00851	0.0244	CcSEcCtD
Bumetanide—SLC12A5—midbrain—brain cancer	0.00832	0.0128	CbGeAlD
Bumetanide—SLC12A5—spinal cord—brain cancer	0.00812	0.0125	CbGeAlD
Bumetanide—SLC12A4—gonad—brain cancer	0.00803	0.0123	CbGeAlD
Bumetanide—Gynaecomastia—Procarbazine—brain cancer	0.00781	0.0224	CcSEcCtD
Bumetanide—CA4—ganglion—brain cancer	0.00776	0.0119	CbGeAlD
Bumetanide—Renal failure—Lomustine—brain cancer	0.00756	0.0217	CcSEcCtD
Bumetanide—SLC12A2—brainstem—brain cancer	0.00748	0.0115	CbGeAlD
Bumetanide—SLC12A5—endocrine gland—brain cancer	0.00731	0.0112	CbGeAlD
Bumetanide—Hyperuricaemia—Hydroxyurea—brain cancer	0.00728	0.0209	CcSEcCtD
Bumetanide—SLC12A5—head—brain cancer	0.00722	0.0111	CbGeAlD
Bumetanide—CA5A—endocrine gland—brain cancer	0.00706	0.0108	CbGeAlD
Bumetanide—Cholestasis—Temozolomide—brain cancer	0.00695	0.02	CcSEcCtD
Bumetanide—SLC12A4—midbrain—brain cancer	0.00691	0.0106	CbGeAlD
Bumetanide—Blood uric acid increased—Hydroxyurea—brain cancer	0.00688	0.0198	CcSEcCtD
Bumetanide—SLC12A4—spinal cord—brain cancer	0.00674	0.0103	CbGeAlD
Bumetanide—SLC12A2—telencephalon—brain cancer	0.00664	0.0102	CbGeAlD
Bumetanide—SLC12A5—central nervous system—brain cancer	0.00659	0.0101	CbGeAlD
Bumetanide—SLC12A5—cerebellum—brain cancer	0.00644	0.00988	CbGeAlD
Bumetanide—Liver injury—Temozolomide—brain cancer	0.00627	0.018	CcSEcCtD
Bumetanide—CA14—telencephalon—brain cancer	0.0062	0.00952	CbGeAlD
Bumetanide—SLC12A4—endocrine gland—brain cancer	0.00607	0.00932	CbGeAlD
Bumetanide—SLC12A4—head—brain cancer	0.00599	0.0092	CbGeAlD
Bumetanide—CA4—hindbrain—brain cancer	0.00589	0.00904	CbGeAlD
Bumetanide—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.00571	0.0164	CcSEcCtD
Bumetanide—SLC12A1—telencephalon—brain cancer	0.00557	0.00855	CbGeAlD
Bumetanide—Hearing impaired—Temozolomide—brain cancer	0.00554	0.0159	CcSEcCtD
Bumetanide—SLC12A2—gonad—brain cancer	0.00554	0.00851	CbGeAlD
Bumetanide—SLC12A4—central nervous system—brain cancer	0.00547	0.0084	CbGeAlD
Bumetanide—SLC12A2—pituitary gland—brain cancer	0.00541	0.0083	CbGeAlD
Bumetanide—Leukopenia—Lomustine—brain cancer	0.00538	0.0154	CcSEcCtD
Bumetanide—Pancreatitis—Procarbazine—brain cancer	0.00537	0.0154	CcSEcCtD
Bumetanide—SLC12A4—cerebellum—brain cancer	0.00535	0.00821	CbGeAlD
Bumetanide—CA7—midbrain—brain cancer	0.00535	0.00821	CbGeAlD
Bumetanide—Musculoskeletal pain—Temozolomide—brain cancer	0.00534	0.0153	CcSEcCtD
Bumetanide—SLC10A1—gonad—brain cancer	0.00524	0.00804	CbGeAlD
Bumetanide—SLC12A5—brain—brain cancer	0.00523	0.00803	CbGeAlD
Bumetanide—SLC12A2—medulla oblongata—brain cancer	0.00522	0.00801	CbGeAlD
Bumetanide—Gynaecomastia—Carmustine—brain cancer	0.00489	0.014	CcSEcCtD
Bumetanide—CA14—medulla oblongata—brain cancer	0.00487	0.00748	CbGeAlD
Bumetanide—CA12—telencephalon—brain cancer	0.00484	0.00742	CbGeAlD
Bumetanide—Thrombocytopenia—Lomustine—brain cancer	0.0048	0.0138	CcSEcCtD
Bumetanide—SLC12A2—midbrain—brain cancer	0.00477	0.00732	CbGeAlD
Bumetanide—CFTR—endocrine gland—brain cancer	0.00477	0.00732	CbGeAlD
Bumetanide—CFTR—head—brain cancer	0.00471	0.00723	CbGeAlD
Bumetanide—Sweating—Procarbazine—brain cancer	0.00468	0.0134	CcSEcCtD
Bumetanide—SLC12A2—spinal cord—brain cancer	0.00465	0.00714	CbGeAlD
Bumetanide—Blood creatinine increased—Hydroxyurea—brain cancer	0.00459	0.0132	CcSEcCtD
Bumetanide—Hyperuricaemia—Etoposide—brain cancer	0.00455	0.0131	CcSEcCtD
Bumetanide—CA14—midbrain—brain cancer	0.00445	0.00684	CbGeAlD
Bumetanide—CA14—spinal cord—brain cancer	0.00435	0.00667	CbGeAlD
Bumetanide—SLC12A4—brain—brain cancer	0.00434	0.00667	CbGeAlD
Bumetanide—Blood uric acid increased—Etoposide—brain cancer	0.0043	0.0123	CcSEcCtD
Bumetanide—SLC12A2—endocrine gland—brain cancer	0.00419	0.00643	CbGeAlD
Bumetanide—Pancreatitis—Hydroxyurea—brain cancer	0.00416	0.0119	CcSEcCtD
Bumetanide—CA7—cerebellum—brain cancer	0.00414	0.00635	CbGeAlD
Bumetanide—SLC12A2—head—brain cancer	0.00414	0.00635	CbGeAlD
Bumetanide—CA9—endocrine gland—brain cancer	0.00413	0.00633	CbGeAlD
Bumetanide—PTGS2—endothelium—brain cancer	0.0041	0.00629	CbGeAlD
Bumetanide—Hyponatraemia—Carmustine—brain cancer	0.00398	0.0114	CcSEcCtD
Bumetanide—SLC10A1—endocrine gland—brain cancer	0.00396	0.00607	CbGeAlD
Bumetanide—SLC10A1—head—brain cancer	0.00391	0.006	CbGeAlD
Bumetanide—SLC12A1—spinal cord—brain cancer	0.0039	0.00599	CbGeAlD
Bumetanide—PTGS2—blood vessel—brain cancer	0.00378	0.0058	CbGeAlD
Bumetanide—SLC12A2—central nervous system—brain cancer	0.00378	0.00579	CbGeAlD
Bumetanide—SLC12A2—cerebellum—brain cancer	0.00369	0.00566	CbGeAlD
Bumetanide—CA9—cerebellum—brain cancer	0.00363	0.00558	CbGeAlD
Bumetanide—CA5B—gonad—brain cancer	0.00362	0.00556	CbGeAlD
Bumetanide—SLC22A11—endocrine gland—brain cancer	0.00361	0.00555	CbGeAlD
Bumetanide—Hypokalaemia—Carmustine—brain cancer	0.00361	0.0104	CcSEcCtD
Bumetanide—SLC10A1—central nervous system—brain cancer	0.00357	0.00547	CbGeAlD
Bumetanide—Dehydration—Temozolomide—brain cancer	0.00356	0.0102	CcSEcCtD
Bumetanide—SLC22A7—endocrine gland—brain cancer	0.00353	0.00541	CbGeAlD
Bumetanide—Hypokalaemia—Temozolomide—brain cancer	0.00349	0.01	CcSEcCtD
Bumetanide—SLC12A1—head—brain cancer	0.00347	0.00532	CbGeAlD
Bumetanide—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.00345	0.0099	CcSEcCtD
Bumetanide—CA14—cerebellum—brain cancer	0.00345	0.00529	CbGeAlD
Bumetanide—Leukopenia—Procarbazine—brain cancer	0.00342	0.00981	CcSEcCtD
Bumetanide—CFTR—brain—brain cancer	0.00341	0.00524	CbGeAlD
Bumetanide—SLCO1A2—telencephalon—brain cancer	0.00339	0.0052	CbGeAlD
Bumetanide—CA4—brainstem—brain cancer	0.00338	0.00518	CbGeAlD
Bumetanide—CA7—brain—brain cancer	0.00336	0.00516	CbGeAlD
Bumetanide—Arthralgia—Procarbazine—brain cancer	0.00325	0.00933	CcSEcCtD
Bumetanide—Dry mouth—Procarbazine—brain cancer	0.00318	0.00912	CcSEcCtD
Bumetanide—SLC12A1—central nervous system—brain cancer	0.00317	0.00486	CbGeAlD
Bumetanide—Vomiting—Lomustine—brain cancer	0.00312	0.00895	CcSEcCtD
Bumetanide—Hyperglycaemia—Carmustine—brain cancer	0.00309	0.00887	CcSEcCtD
Bumetanide—CA12—endocrine gland—brain cancer	0.00305	0.00468	CbGeAlD
Bumetanide—Thrombocytopenia—Procarbazine—brain cancer	0.00305	0.00875	CcSEcCtD
Bumetanide—CA12—head—brain cancer	0.00301	0.00462	CbGeAlD
Bumetanide—Hyperhidrosis—Procarbazine—brain cancer	0.00301	0.00864	CcSEcCtD
Bumetanide—Renal failure—Carmustine—brain cancer	0.003	0.00862	CcSEcCtD
Bumetanide—SLC12A2—brain—brain cancer	0.003	0.0046	CbGeAlD
Bumetanide—CA4—telencephalon—brain cancer	0.003	0.0046	CbGeAlD
Bumetanide—Hyperglycaemia—Temozolomide—brain cancer	0.00299	0.00857	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00293	0.0084	CcSEcCtD
Bumetanide—Nausea—Lomustine—brain cancer	0.00291	0.00836	CcSEcCtD
Bumetanide—Hypotension—Procarbazine—brain cancer	0.00291	0.00835	CcSEcCtD
Bumetanide—SLC10A1—brain—brain cancer	0.00283	0.00435	CbGeAlD
Bumetanide—CA14—brain—brain cancer	0.0028	0.0043	CbGeAlD
Bumetanide—Toxic epidermal necrolysis—Etoposide—brain cancer	0.00276	0.00793	CcSEcCtD
Bumetanide—Cramp muscle—Etoposide—brain cancer	0.00276	0.00793	CcSEcCtD
Bumetanide—CA12—central nervous system—brain cancer	0.00275	0.00422	CbGeAlD
Bumetanide—CA5B—endocrine gland—brain cancer	0.00274	0.0042	CbGeAlD
Bumetanide—CA5B—head—brain cancer	0.0027	0.00415	CbGeAlD
Bumetanide—Fatigue—Procarbazine—brain cancer	0.00269	0.00771	CcSEcCtD
Bumetanide—SLCO1A2—medulla oblongata—brain cancer	0.00266	0.00408	CbGeAlD
Bumetanide—Leukopenia—Hydroxyurea—brain cancer	0.00264	0.00759	CcSEcCtD
Bumetanide—Gastrointestinal pain—Procarbazine—brain cancer	0.00255	0.00731	CcSEcCtD
Bumetanide—SLC22A7—brain—brain cancer	0.00252	0.00387	CbGeAlD
Bumetanide—SLC12A1—brain—brain cancer	0.00251	0.00386	CbGeAlD
Bumetanide—Erythema multiforme—Temozolomide—brain cancer	0.00251	0.00719	CcSEcCtD
Bumetanide—Urticaria—Procarbazine—brain cancer	0.00247	0.0071	CcSEcCtD
Bumetanide—CA5B—central nervous system—brain cancer	0.00247	0.00379	CbGeAlD
Bumetanide—Abdominal pain—Procarbazine—brain cancer	0.00246	0.00707	CcSEcCtD
Bumetanide—CA4—pituitary gland—brain cancer	0.00244	0.00374	CbGeAlD
Bumetanide—SLC22A6—brain—brain cancer	0.00244	0.00374	CbGeAlD
Bumetanide—SLCO1A2—midbrain—brain cancer	0.00243	0.00373	CbGeAlD
Bumetanide—SLCO1A2—spinal cord—brain cancer	0.00237	0.00364	CbGeAlD
Bumetanide—Thrombocytopenia—Hydroxyurea—brain cancer	0.00236	0.00677	CcSEcCtD
Bumetanide—CA4—medulla oblongata—brain cancer	0.00235	0.00361	CbGeAlD
Bumetanide—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00234	0.00672	CcSEcCtD
Bumetanide—Renal failure—Etoposide—brain cancer	0.00232	0.00667	CcSEcCtD
Bumetanide—Asthenia—Procarbazine—brain cancer	0.00223	0.00641	CcSEcCtD
Bumetanide—Pruritus—Procarbazine—brain cancer	0.0022	0.00633	CcSEcCtD
Bumetanide—CA12—brain—brain cancer	0.00218	0.00335	CbGeAlD
Bumetanide—CA4—midbrain—brain cancer	0.00215	0.0033	CbGeAlD
Bumetanide—Leukopenia—Carmustine—brain cancer	0.00214	0.00614	CcSEcCtD
Bumetanide—SLCO1A2—endocrine gland—brain cancer	0.00214	0.00328	CbGeAlD
Bumetanide—Diarrhoea—Procarbazine—brain cancer	0.00213	0.00612	CcSEcCtD
Bumetanide—SLCO1A2—head—brain cancer	0.00211	0.00324	CbGeAlD
Bumetanide—CA4—spinal cord—brain cancer	0.0021	0.00322	CbGeAlD
Bumetanide—Fatigue—Hydroxyurea—brain cancer	0.00208	0.00597	CcSEcCtD
Bumetanide—Vertigo—Temozolomide—brain cancer	0.00207	0.00595	CcSEcCtD
Bumetanide—Leukopenia—Temozolomide—brain cancer	0.00207	0.00593	CcSEcCtD
Bumetanide—Dizziness—Procarbazine—brain cancer	0.00206	0.00591	CcSEcCtD
Bumetanide—Chest pain—Carmustine—brain cancer	0.00203	0.00584	CcSEcCtD
Bumetanide—SLC22A8—head—brain cancer	0.00201	0.00309	CbGeAlD
Bumetanide—Erythema multiforme—Etoposide—brain cancer	0.00201	0.00576	CcSEcCtD
Bumetanide—Vomiting—Procarbazine—brain cancer	0.00198	0.00568	CcSEcCtD
Bumetanide—Arthralgia—Temozolomide—brain cancer	0.00196	0.00564	CcSEcCtD
Bumetanide—Rash—Procarbazine—brain cancer	0.00196	0.00564	CcSEcCtD
Bumetanide—Dermatitis—Procarbazine—brain cancer	0.00196	0.00563	CcSEcCtD
Bumetanide—CA5B—brain—brain cancer	0.00196	0.00301	CbGeAlD
Bumetanide—Headache—Procarbazine—brain cancer	0.00195	0.0056	CcSEcCtD
Bumetanide—SLCO1A2—central nervous system—brain cancer	0.00192	0.00295	CbGeAlD
Bumetanide—Dry mouth—Temozolomide—brain cancer	0.00192	0.00551	CcSEcCtD
Bumetanide—Thrombocytopenia—Carmustine—brain cancer	0.00191	0.00548	CcSEcCtD
Bumetanide—CA4—endocrine gland—brain cancer	0.00189	0.0029	CbGeAlD
Bumetanide—SLCO1A2—cerebellum—brain cancer	0.00188	0.00289	CbGeAlD
Bumetanide—CA4—head—brain cancer	0.00187	0.00286	CbGeAlD
Bumetanide—Nausea—Procarbazine—brain cancer	0.00185	0.00531	CcSEcCtD
Bumetanide—Thrombocytopenia—Temozolomide—brain cancer	0.00184	0.00529	CcSEcCtD
Bumetanide—SLC22A8—central nervous system—brain cancer	0.00184	0.00282	CbGeAlD
Bumetanide—PTGS2—telencephalon—brain cancer	0.00183	0.00281	CbGeAlD
Bumetanide—Hypotension—Carmustine—brain cancer	0.00182	0.00523	CcSEcCtD
Bumetanide—Hyperhidrosis—Temozolomide—brain cancer	0.00182	0.00523	CcSEcCtD
Bumetanide—Muscle spasms—Etoposide—brain cancer	0.00178	0.0051	CcSEcCtD
Bumetanide—Asthenia—Hydroxyurea—brain cancer	0.00173	0.00496	CcSEcCtD
Bumetanide—CA4—central nervous system—brain cancer	0.0017	0.00261	CbGeAlD
Bumetanide—CA4—cerebellum—brain cancer	0.00166	0.00255	CbGeAlD
Bumetanide—Vertigo—Etoposide—brain cancer	0.00166	0.00476	CcSEcCtD
Bumetanide—Leukopenia—Etoposide—brain cancer	0.00165	0.00474	CcSEcCtD
Bumetanide—Diarrhoea—Hydroxyurea—brain cancer	0.00165	0.00473	CcSEcCtD
Bumetanide—Fatigue—Temozolomide—brain cancer	0.00162	0.00466	CcSEcCtD
Bumetanide—Dizziness—Hydroxyurea—brain cancer	0.00159	0.00458	CcSEcCtD
Bumetanide—Gastrointestinal pain—Carmustine—brain cancer	0.00159	0.00457	CcSEcCtD
Bumetanide—Chest pain—Etoposide—brain cancer	0.00157	0.00451	CcSEcCtD
Bumetanide—Abdominal pain—Carmustine—brain cancer	0.00154	0.00442	CcSEcCtD
Bumetanide—Gastrointestinal pain—Temozolomide—brain cancer	0.00154	0.00442	CcSEcCtD
Bumetanide—Vomiting—Hydroxyurea—brain cancer	0.00153	0.0044	CcSEcCtD
Bumetanide—SLCO1A2—brain—brain cancer	0.00153	0.00234	CbGeAlD
Bumetanide—Rash—Hydroxyurea—brain cancer	0.00152	0.00436	CcSEcCtD
Bumetanide—Dermatitis—Hydroxyurea—brain cancer	0.00152	0.00436	CcSEcCtD
Bumetanide—Headache—Hydroxyurea—brain cancer	0.00151	0.00433	CcSEcCtD
Bumetanide—Urticaria—Temozolomide—brain cancer	0.0015	0.00429	CcSEcCtD
Bumetanide—PTGS2—pituitary gland—brain cancer	0.00149	0.00229	CbGeAlD
Bumetanide—Abdominal pain—Temozolomide—brain cancer	0.00149	0.00427	CcSEcCtD
Bumetanide—Thrombocytopenia—Etoposide—brain cancer	0.00148	0.00424	CcSEcCtD
Bumetanide—SLC22A8—brain—brain cancer	0.00146	0.00224	CbGeAlD
Bumetanide—Hyperhidrosis—Etoposide—brain cancer	0.00146	0.00418	CcSEcCtD
Bumetanide—PTGS2—medulla oblongata—brain cancer	0.00144	0.00221	CbGeAlD
Bumetanide—Nausea—Hydroxyurea—brain cancer	0.00143	0.00411	CcSEcCtD
Bumetanide—Hypotension—Etoposide—brain cancer	0.00141	0.00404	CcSEcCtD
Bumetanide—Asthenia—Carmustine—brain cancer	0.0014	0.00401	CcSEcCtD
Bumetanide—CA4—brain—brain cancer	0.00135	0.00207	CbGeAlD
Bumetanide—Asthenia—Temozolomide—brain cancer	0.00135	0.00388	CcSEcCtD
Bumetanide—Diarrhoea—Carmustine—brain cancer	0.00133	0.00383	CcSEcCtD
Bumetanide—Pruritus—Temozolomide—brain cancer	0.00133	0.00382	CcSEcCtD
Bumetanide—PTGS2—midbrain—brain cancer	0.00132	0.00202	CbGeAlD
Bumetanide—Fatigue—Etoposide—brain cancer	0.0013	0.00373	CcSEcCtD
Bumetanide—Dizziness—Carmustine—brain cancer	0.00129	0.0037	CcSEcCtD
Bumetanide—Diarrhoea—Temozolomide—brain cancer	0.00129	0.0037	CcSEcCtD
Bumetanide—PTGS2—spinal cord—brain cancer	0.00128	0.00197	CbGeAlD
Bumetanide—Dizziness—Temozolomide—brain cancer	0.00125	0.00357	CcSEcCtD
Bumetanide—Vomiting—Carmustine—brain cancer	0.00124	0.00356	CcSEcCtD
Bumetanide—Gastrointestinal pain—Etoposide—brain cancer	0.00123	0.00354	CcSEcCtD
Bumetanide—Rash—Carmustine—brain cancer	0.00123	0.00353	CcSEcCtD
Bumetanide—Dermatitis—Carmustine—brain cancer	0.00123	0.00352	CcSEcCtD
Bumetanide—Headache—Carmustine—brain cancer	0.00122	0.0035	CcSEcCtD
Bumetanide—Vomiting—Temozolomide—brain cancer	0.0012	0.00344	CcSEcCtD
Bumetanide—Urticaria—Etoposide—brain cancer	0.0012	0.00344	CcSEcCtD
Bumetanide—Abdominal pain—Etoposide—brain cancer	0.00119	0.00342	CcSEcCtD
Bumetanide—Rash—Temozolomide—brain cancer	0.00119	0.00341	CcSEcCtD
Bumetanide—Dermatitis—Temozolomide—brain cancer	0.00119	0.00341	CcSEcCtD
Bumetanide—Headache—Temozolomide—brain cancer	0.00118	0.00339	CcSEcCtD
Bumetanide—Nausea—Carmustine—brain cancer	0.00116	0.00332	CcSEcCtD
Bumetanide—PTGS2—endocrine gland—brain cancer	0.00116	0.00177	CbGeAlD
Bumetanide—PTGS2—head—brain cancer	0.00114	0.00175	CbGeAlD
Bumetanide—Nausea—Temozolomide—brain cancer	0.00112	0.00321	CcSEcCtD
Bumetanide—Asthenia—Etoposide—brain cancer	0.00108	0.0031	CcSEcCtD
Bumetanide—Pruritus—Etoposide—brain cancer	0.00107	0.00306	CcSEcCtD
Bumetanide—PTGS2—central nervous system—brain cancer	0.00104	0.0016	CbGeAlD
Bumetanide—Diarrhoea—Etoposide—brain cancer	0.00103	0.00296	CcSEcCtD
Bumetanide—PTGS2—cerebellum—brain cancer	0.00102	0.00156	CbGeAlD
Bumetanide—Dizziness—Etoposide—brain cancer	0.000996	0.00286	CcSEcCtD
Bumetanide—Vomiting—Etoposide—brain cancer	0.000958	0.00275	CcSEcCtD
Bumetanide—Rash—Etoposide—brain cancer	0.00095	0.00273	CcSEcCtD
Bumetanide—Dermatitis—Etoposide—brain cancer	0.000949	0.00272	CcSEcCtD
Bumetanide—Headache—Etoposide—brain cancer	0.000944	0.00271	CcSEcCtD
Bumetanide—Nausea—Etoposide—brain cancer	0.000895	0.00257	CcSEcCtD
Bumetanide—PTGS2—brain—brain cancer	0.000827	0.00127	CbGeAlD
